Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:BIOA

(BIOA) (BIOA) Stock Price, News & Analysis

(BIOA) logo

About (BIOA) Stock (NYSE:BIOA)

Advanced Chart

Key Stats

Today's Range
$4.40
$5.00
50-Day Range
N/A
52-Week Range
$2.88
$26.62
Volume
512,188 shs
Average Volume
458,080 shs
Market Capitalization
$163.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.67
Consensus Rating
Reduce

Company Overview

Receive BIOA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (BIOA) and its competitors with MarketBeat's FREE daily newsletter.

BIOA Stock News Headlines

Bioage Labs Inc BIOA
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
BioAge Labs, Inc. Common Stock (BIOA)
BioAge Labs completes IND-enabling studies for BGE-102
See More Headlines

BIOA Stock Analysis - Frequently Asked Questions

(BIOA) (NYSE:BIOA) issued its quarterly earnings data on Thursday, November, 7th. The biotechnology company reported ($6.70) EPS for the quarter, missing analysts' consensus estimates of ($0.62) by $6.08.

(BIOA) (BIOA) raised $198 million in an initial public offering (IPO) on Thursday, September 26th 2024. The company issued 11,000,000 shares at a price of $18.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that (BIOA) investors own include ProQR Therapeutics (PRQR), Flexion Therapeutics (FLXN), Rite Aid (RAD), LadRx (CYTR), Intellipharmaceutics International (IPCIF), NVIDIA (NVDA) and AbbVie (ABBV).

Company Calendar

Last Earnings
11/07/2024
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:BIOA
CIK
1534287
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$7.00
Low Price Target
$5.00
Potential Upside/Downside
+24.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
35,850,000
Free Float
N/A
Market Cap
$163.83 million
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:BIOA) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners